GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioservo Technologies AB (OSTO:BIOS) » Definitions » Interest Expense

Bioservo Technologies AB (OSTO:BIOS) Interest Expense : kr-0.03 Mil (TTM As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Bioservo Technologies AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bioservo Technologies AB's interest expense for the three months ended in Sep. 2023 was kr 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was kr-0.03 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bioservo Technologies AB's Operating Income for the three months ended in Sep. 2023 was kr -9.76 Mil. Bioservo Technologies AB's Interest Expense for the three months ended in Sep. 2023 was kr 0.00 Mil. Bioservo Technologies AB has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Bioservo Technologies AB Interest Expense Historical Data

The historical data trend for Bioservo Technologies AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioservo Technologies AB Interest Expense Chart

Bioservo Technologies AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Interest Expense
Get a 7-Day Free Trial -0.01 -0.01 - -0.01 -0.01

Bioservo Technologies AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - -0.01 -0.02 -

Bioservo Technologies AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioservo Technologies AB  (OSTO:BIOS) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bioservo Technologies AB's Interest Expense for the three months ended in Sep. 2023 was kr0.00 Mil. Its Operating Income for the three months ended in Sep. 2023 was kr-9.76 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was kr0.00 Mil.

Bioservo Technologies AB's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Bioservo Technologies AB had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Bioservo Technologies AB (OSTO:BIOS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioservo Technologies AB (OSTO:BIOS) » Definitions » Interest Expense
Comparable Companies
XSAT:MEDIMI XSAT:ODIN XSAT:AUDNTS OSTO:S2M XSAT:EURI B XSAT:BIBB NGM:PRLD OSTO:IZAFE B OSTO:ORTI A ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN BAX
Traded in Other Exchanges
N/A
Address
Torshamnsgatan 35, Kista, SWE, 164 40
Website
https://www.bioservo.com
Bioservo Technologies AB is a Sweden based wearable muscle strengthening systems provider company. It develops wearable technologies based on bionic soft robotics. The company offers SEM Gloves, a grip strengthening aid designed for people with impaired hand function or grip-intensive occupations.